From the Guidelines
The first-line management for primary hypertension should include lifestyle modifications and medication therapy, with a target blood pressure of less than 130/80 mmHg, and first-line agents including thiazide diuretics, calcium channel blockers, ACE inhibitors, or angiotensin II receptor blockers, as recommended by the 2017 American College of Cardiology/American Heart Association hypertension guideline 1.
Key Lifestyle Modifications
- Regular physical activity (150 minutes of moderate-intensity exercise per week)
- Weight reduction if overweight
- Adopting the DASH diet (rich in fruits, vegetables, whole grains, and low-fat dairy products)
- Sodium restriction to less than 2.3g per day
- Limiting alcohol consumption
- Smoking cessation
First-Line Medication Therapy
- Thiazide diuretics (such as hydrochlorothiazide 12.5-25mg daily)
- Calcium channel blockers (like amlodipine 5-10mg daily)
- ACE inhibitors (such as lisinopril 10-40mg daily)
- Angiotensin II receptor blockers (such as losartan 50-100mg daily) The choice of medication should be individualized based on patient characteristics, comorbidities, and potential side effects, with ACE inhibitors or ARBs preferred in patients with diabetes or chronic kidney disease, as supported by the 2019 Standards of Medical Care in Diabetes 1. Combination therapy may be necessary if blood pressure goals are not achieved with a single agent.
Special Considerations
- For patients with stage 2 hypertension, initiation of 2 antihypertensive agents from different classes is recommended when the average SBP and DBP are more than 20 and 10 mm Hg above target, respectively 1.
- For patients with diabetes, the target blood pressure is less than 130/80 mmHg, and ACE inhibitors or ARBs are recommended as first-line agents 1.
From the FDA Drug Label
Many patients will require more than 1 drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program’s Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC)
The first-line management for primary hypertension is not explicitly stated in the provided drug labels. However, it is mentioned that control of high blood pressure should be part of comprehensive cardiovascular risk management, including:
- Lipid control
- Diabetes management
- Antithrombotic therapy
- Smoking cessation
- Exercise
- Limited sodium intake It is also stated that many patients will require more than 1 drug to achieve blood pressure goals, and that numerous antihypertensive drugs have been shown to reduce cardiovascular morbidity and mortality 2 3.
From the Research
First-Line Management for Primary Hypertension
The first-line management for primary hypertension involves a combination of lifestyle modifications and, if necessary, pharmacologic therapy.
- Lifestyle modifications are the initial approach and include:
- Weight loss for overweight or obese individuals
- Healthy dietary patterns with low sodium and high potassium intake
- Regular physical activity
- Moderation or elimination of alcohol consumption
- Stress reduction techniques As noted in studies 4, 5, 6, 7, 8, these modifications can help lower blood pressure and reduce the risk of cardiovascular disease.
Pharmacologic Therapy
If lifestyle modifications are insufficient to control blood pressure, pharmacologic therapy may be initiated.
- First-line drug therapy for hypertension consists of:
- Thiazide or thiazide-like diuretics (e.g., hydrochlorothiazide or chlorthalidone)
- Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (e.g., enalapril or candesartan)
- Calcium channel blockers (e.g., amlodipine) As discussed in 4, these medications should be titrated according to office and home blood pressure levels to achieve target blood pressure goals.
Importance of Lifestyle Modifications
Lifestyle modifications are essential for the management of primary hypertension, as they can help reduce blood pressure and minimize the need for pharmacologic therapy.